电子急性肾损伤预警对成人住院患者预后的影响:系统评价与Meta分析
该系统评价与Meta分析检索PubMed、Cochrane Central Register of Controlled Trials、Cochrane Library和Web of Science从建库至2024年11月,纳入22项研究共170,696例住院患者,其中8项RCT(n=21,710)和14项非RCT或观察性研究(n=148,986)。RCT显示AKI预警对死亡率(RR 1.02;95%CI 0.97-1.07)和住院时长(均数差0.04;95%CI -0.13至0.22)无影响,但显著增加RRT使用(RR 1.13;95%CI 1.02-1.26)。非RCT显示死亡率降低(RR 0.92;95%CI 0.88-0.96)、AKI进展减少(RR 0.85;95%CI 0.77-0.94)、肾脏恢复增加(RR 1.65;95%CI 1.56-1.75)、停用肾毒性药物增加(RR 1.20;95%CI 1.13-1.28)和药物审查率增加(RR 1.19;95%CI 1.17-1.21),对RRT使用无影响(RR 1.08;95%CI 0.87-1.36)。结论认为AKI预警的疗效尚不确定,当前证据既不支持也不反驳其有效性,应答强度、医院类型和地理区域的差异可能解释不一致性,需进一步研究以优化AKI预警系统在临床实践中采取更有效行动。
要点
- RCT汇总显示AKI电子预警对死亡率无影响(RR 1.02;95%CI 0.97-1.07),但RRT使用显著增加(RR 1.13;95%CI 1.02-1.26)。
- 非RCT汇总显示AKI预警与死亡率降低(RR 0.92;95%CI 0.88-0.96)和AKI进展减少(RR 0.85;95%CI 0.77-0.94)相关,对RRT使用无影响(RR 1.08;95%CI 0.87-1.36)。
- 亚组分析显示低应答强度组院内死亡率增加(RR 1.15;95%CI 1.00-1.32),中应答强度组死亡率降低(RR 0.93;95%CI 0.89-0.97),高应答强度组效应不明确(RR 0.88;95%CI 0.70-1.09)。
- 非RCT中AKI预警与停用肾毒性药物增加(RR 1.20;95%CI 1.13-1.28)和药物审查率增加(RR 1.19;95%CI 1.17-1.21)相关。
- AKI预警在教学医院和欧洲、北美及南美等地区更受支持;作者认为应答强度、医院类型和地理区域差异可能解释研究间不一致。
适用人群与场景
- 成人住院患者(纳入RCT、前后对照分析和阶梯楔形设计研究)。
研究设计与关键结果
- 系统评价与Meta分析纳入22项研究共170,696例参与者:8项RCT(n=21,710)和14项非RCT或观察性研究(n=148,986)。
- RCT:AKI预警对死亡率无影响(RR 1.02;95%CI 0.97-1.07),对住院时长无影响(均数差0.04;95%CI -0.13至0.22),RRT使用显著增加(RR 1.13;95%CI 1.02-1.26)。
- 非RCT:死亡率降低(RR 0.92;95%CI 0.88-0.96),AKI进展减少(RR 0.85;95%CI 0.77-0.94),肾脏恢复增加(RR 1.65;95%CI 1.56-1.75),停用肾毒性药物增加(RR 1.20;95%CI 1.13-1.28),药物审查率增加(RR 1.19;95%CI 1.17-1.21),RRT使用无影响(RR 1.08;95%CI 0.87-1.36)。
- 亚组分析:低应答强度组院内死亡率增加(RR 1.15;95%CI 1.00-1.32),中应答强度组死亡率降低(RR 0.93;95%CI 0.89-0.97),高应答强度组效应不明确(RR 0.88;95%CI 0.70-1.09)。
- AKI预警在教学医院和欧洲、北美及南美等地区更受支持。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入RCT、前后对照分析和阶梯楔形设计研究。
- 作者结论:AKI预警的疗效尚不确定,当前证据既不支持也不反驳其有效性。
- 局限:应答强度、医院类型和地理区域存在变异性,可能解释研究间不一致;作者指出需进一步研究以优化AKI预警系统在临床实践中采取更有效行动。
对床旁实践的改变
- RCT证据显示AKI电子预警未降低死亡率且增加RRT使用(RR 1.13;95%CI 1.02-1.26),非RCT显示死亡率降低(RR 0.92;95%CI 0.88-0.96),当前证据既不支持也不反驳其有效性。
- 作者认为应答强度、医院类型和地理区域差异可能解释研究间不一致,需进一步研究以优化AKI预警系统在临床实践中采取更有效行动。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute kidney injury (AKI) is a critical yet frequently under diagnosed condition in hospitalized patients, impacting morbidity and mortality. Electronic alerts for AKI aimed to assist physicians in early diagnosis and intervention, though evidence for their effectiveness is inconsistent.
MATERIALS AND METHODS: A systematic search was conducted in PubMed, the Cochrane Central Register of Controlled Trials, Cochrane Library, and Web of Science from inception to November 2024. Eligible studies included randomized controlled trials (RCTs), before-and-after analyses, and stepped-wedge designs involving hospitalized patients. The primary outcomes were mortality and renal replacement therapy (RRT) rates, Secondary outcomes included hospital length of stay (LoS), AKI progression and recovery. Care-centered outcomes encompassed nephrologist consultation, nephrotoxic medication discontinuation and medication review. Subgroup analysis examined the impact of response intensity, hospital type and geographic region on these outcomes.
RESULTS: Twenty-two studies involving 170,696 participants were included: 8 RCTs (n = 21,710) and 14 non-RCTs or observational studies (n = 148,986). RCTs showed no effect on mortality (RR 1.02; 95% CI 0.97-1.07) or LoS (mean difference 0.04; 95% CI - 0.13 to 0.22) but a significant increase in RRT use (RR 1.13; 95% CI 1.02-1.26) with AKI alert systems. Non-RCTs, however, reported reduced mortality (RR 0.92; 95% CI 0.88-0.96), less AKI progression (RR 0.85; 95% CI 0.77-0.94), enhanced kidney recovery (RR 1.65; 95% CI 1.56-1.75), increased nephrotoxic drug discontinuation (RR 1.20; 95% CI 1.13-1.28), and higher drug review rates (RR 1.19; 95% CI 1.17-1.21), with no impact on RRT use (RR 1.08; 95% CI 0.87-1.36). Subgroup analysis revealed an increased in-hospital mortality in low response intensity (RR 1.15; 95% CI 1.00-1.32), reduced mortality in moderate response intensity (RR 0.93; 95% CI 0.89-0.97), and unclear effects in high response intensity (RR 0.88; 95% CI 0.70-1.09). AKI alert was also favored in teaching hospitals and in several regions (Europe, North America and South America).
CONCLUSION: The efficacy of AKI alerts remains inconclusive. Current evidence do not support or refute their effectiveness. Variability in response intensity, hospital type and geographic region may help explaining discrepancies, underscoring the need for further research to optimize AKI alert systems with more effective action in clinical practice.
参考来源
- Wang H, Deng L, Li T, et al. The influence of electronic AKI alert on prognosis of adult hospitalized patients: a systematic review and meta-analysis. Crit Care. 2025. PMID: 40355901. doi:10.1186/s13054-025-05402-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。